Harald Olsen

1.1k total citations
56 papers, 878 citations indexed

About

Harald Olsen is a scholar working on Physiology, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Harald Olsen has authored 56 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 11 papers in Pharmacology and 8 papers in Clinical Biochemistry. Recurrent topics in Harald Olsen's work include Pharmacogenetics and Drug Metabolism (8 papers), Metabolism and Genetic Disorders (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Harald Olsen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Metabolism and Genetic Disorders (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Harald Olsen collaborates with scholars based in Norway, United States and Sweden. Harald Olsen's co-authors include Jørg Mørland, Magne Arve Flaten, Terje Simonsen, J. C. Gilson, Anders Andersen, Gunnar Alván, Steinar Aamdal, Paal Brunsvig, Erling O. Koppang and Ulf E. Kongsgaard and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Psychopharmacology.

In The Last Decade

Harald Olsen

51 papers receiving 786 citations

Peers

Harald Olsen
A. Darragh Ireland
Allen A. Lai United States
Willi Weber Germany
M. De Smet Belgium
G. Nyberg Sweden
Weidong Lu United States
D R Abernethy United States
S. Fred Brunk United States
A. Gordin Finland
A. Darragh Ireland
Harald Olsen
Citations per year, relative to Harald Olsen Harald Olsen (= 1×) peers A. Darragh

Countries citing papers authored by Harald Olsen

Since Specialization
Citations

This map shows the geographic impact of Harald Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Olsen more than expected).

Fields of papers citing papers by Harald Olsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Olsen. The network helps show where Harald Olsen may publish in the future.

Co-authorship network of co-authors of Harald Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Olsen. A scholar is included among the top collaborators of Harald Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Olsen. Harald Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edvardsen, Hege, Paal Brunsvig, Hiroko Kato Solvang, et al.. (2010). SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance. The Pharmacogenomics Journal. 10(6). 513–523. 18 indexed citations
3.
Kongsgaard, Ulf E., et al.. (2009). Infusions of albumin increase free fraction of naproxen in healthy volunteers: a randomized crossover study. Acta Anaesthesiologica Scandinavica. 54(4). 430–434. 2 indexed citations
4.
Kongsgaard, Ulf E., et al.. (2008). Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES. Acta Anaesthesiologica Scandinavica. 52(3). 406–412. 7 indexed citations
5.
Torfoss, Dag, E. Arne Høiby, Jon Magnus Tangen, et al.. (2007). Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. Journal of Antimicrobial Chemotherapy. 59(4). 711–717. 19 indexed citations
6.
Brunsvig, Paal, Anders Andersen, Steinar Aamdal, Vessela N. Kristensen, & Harald Olsen. (2007). Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy. BMC Cancer. 7(1). 197–197. 34 indexed citations
7.
Gotlieb, Walter H., Ilan Bruchim, Gilad Ben‐Baruch, et al.. (2006). Doxorubicin levels in the serum and ascites of patients with ovarian cancer. European Journal of Surgical Oncology. 33(2). 213–215. 10 indexed citations
8.
Andersen, Anders, David J. Warren, Paal Brunsvig, et al.. (2006). High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. PubMed. 6(1). 2–2. 59 indexed citations
9.
Flaten, Magne Arve, et al.. (2004). Stimulant and relaxant drugs combined with stimulant and relaxant information: a study of active placebo. Psychopharmacology. 176(3-4). 426–434. 16 indexed citations
10.
Olsen, Harald, et al.. (2004). Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro. PubMed. 4(1). 4–4. 51 indexed citations
11.
Waal, Helge, et al.. (2003). [Use of naltrexone in the treatment of young drug addicts].. PubMed. 123(12). 1662–4. 1 indexed citations
12.
Westheim, Arne, et al.. (2001). Blood Pressure Levels in Treated Hypertensive Patients in General Practice in Norway. Blood Pressure. 10(1). 37–42. 36 indexed citations
13.
Flaten, Magne Arve, Terje Simonsen, & Harald Olsen. (1999). Drug-Related Information Generates Placebo and Nocebo Responses That Modify the Drug Response. Psychosomatic Medicine. 61(2). 250–255. 144 indexed citations
14.
Olsen, Harald, Erling O. Koppang, Gunnar Alván, & Jørg Mørland. (1994). Carisoprodol Elimination in Humans. Therapeutic Drug Monitoring. 16(4). 337–340. 52 indexed citations
15.
Olsen, Harald, et al.. (1993). Influence of ethanol ingestion on the cornea. Acta Ophthalmologica. 71(5). 696–698. 11 indexed citations
16.
Olsen, Harald, et al.. (1988). An Experimental Study on Ethanol Elimination at Subphysiological Temperatures. Pharmacology & Toxicology. 62(2). 118–120. 1 indexed citations
17.
Olsen, Harald & Bjarne Østerud. (1987). Effects of ethanol on human blood fibrinolysis and coagulation.. PubMed. 1. 591–4. 14 indexed citations
18.
Olsen, Harald, et al.. (1986). The Effect of Ethanol Intake on Propoxyphene Absorption and Biotransformation in Dogs. Alcoholism Clinical and Experimental Research. 10(4). 393–396. 2 indexed citations
19.
Olsen, Harald & Jørg Mørland. (1978). Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.. BMJ. 2(6147). 1260–1262. 55 indexed citations
20.
Mørland, Jørg & Harald Olsen. (1977). Metabolism of sulfadimidine, sulfanilamide, p-aminobenzoic acid, and isoniazid in suspensions of parenchymal and nonparenchymal rat liver cells.. Drug Metabolism and Disposition. 5(6). 511–517. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026